NCT01539239 - Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON) | Biotech Hunter

Enrollment

1,143

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2020

Conditions

Primary Open Angle Glaucoma

Interventions

DEVICE

Hydrus Aqueous Implant

The Hydrus Aqueous Implant is a crescent-shaped nitinol device intended to be a permanent implant placed through the trabecular meshwork into Schlemm's Canal, immediately following placement of a monofocal IOL.

PROCEDURE

Cataract surgery

A monofocal intraocular lens (IOL) placed during the cataract surgery.

Trial Locations (38)

Unknown

Phoenix

Tucson

Fayetteville

La Jolla

Orange

Sacramento

Fort Collins

Parker

Bradenton

Fort Myers

Ocala

Sioux City

Garden City

Louisville

Sandwich

Bloomington

Chesterfield

Wilmington

Cleveland

Mason

Maryville

Austin

Dallas

Fort Worth

Salt Lake City

Racine

Edmonton

Boisbriand

Mainz

Parma

Tijuana

Manila

Warsaw

Madrid

Zaragoza

London

Manchester

Norwich